Attenuation of cyclic AMP production by carbamazepine

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 2079-2086

  Chen, Guang ^a   Pan, Baishen ^c   Hawver, David B ^c   Wright, Clinton B ^c   Potter, William Z ^c   Manji, Husseini K ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Adenylyl cyclase; Anticonvulsant; Carbamazepine; Cyclic AMP response element binding protein; Mania; Seizure

Indexed keywords

ADENYLATE CYCLASE; CARBAMAZEPINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; GLIOMA CELL; MALE; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029848644     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67052079.x     Document Type: Article

References (52)

1. Chen G., Manji H. K., Hawver D. B., Wright C. B., and Potter W. Z. (1994) Chronic sodium valproate selectively decreases protein kinase C α and ε in vitro. J. Neurochem. 63, 2361-2364.
2. Chen G., Manji H. K., Hawver D. B., Wright C. B., and Potter W. Z. (1996) Effects of valproic acid on β-adrenergic receptors, G-proteins and adenylate cyclase in rat C6 glioma cells. Neuropsychopharmacology (in press).
3. Divish M. M., Sheftel G., Boyle A., Kalasapudi V. D., Papolos D. F., and Lachman H. M. (1991) Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. J Neurosci. Res. 28, 40-48.
4. Elphick M., Taghavi Z., Powell T., and Godfrey P. P. (1990) Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD116,948. Psychopharmacology (Berl.) 100, 522-529.
5. Ferrendelli J. A. and Kinscherf D. A. (1979) Inhibitory effects of anticonvulsant drugs on cyclic nucleotide accumulation in brain. Ann. Neurol. 5, 533-538.
6. Gessa G. A., Krishna G., Forn J., Tagliamonte A., and Brodie B. B. (1970) Behavioral and vegetative effects produced by dibutyryl cyclic AMP injected into different areas of the brain, in Advances in Biochemical Psychopharmacology, Vol. 3 (Greengard P. and Costa E., eds), pp. 371-381. Raven Press, New York.
7. Ginty D. D., Kornhauser J. M., Thompson M. A., Bading H., Mayo K. E., Takahashi J. S., and Greenberg M. E. (1993) Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 260, 238-241.
8. Goodwin F. K. and Jamison K. R. (1990) Manic-Depressive Illness. Oxford University Press, New York.
9. Greengard P., Jen J., Nairn A. C., and Stevens C. F. (1991) Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocappal neurons. Science 253, 1135-1138.
10. Hudson C. J., Young L. T., Li P. P., and Warsh J. J. (1993) CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13, 278-293.
11. Kramlinger K. G. and Post R. M. (1989a) The addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant mania. Arch. Gen. Psychiatry 46, 794-800.
12. Kramlinger K. G. and Post R. M. (1989b) Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatry Scand. 79, 378-385.
13. Kuriyama K. and Kakita K. (1980) Cholera toxin induced epileptogenic focus: an animal model for studying roles of cyclic AMP in the establishment of epilepsy, in Neurochemistry and Clinical Neurology (Battistin L., ed), pp. 141-155. Alan R. Liss, New York.
14. 3H] forskolin. Methods Enzymol. 195, 52-65.
15. Lee K. A. (1991) Transcriptional regulation by cAMP. Curr. Opin. Cell Biol. 3, 953-959.
16. Levitan I. B. (1994) Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu. Rev. Physiol. 56, 193-212.
17. Lewin E. and Bleck V. (1977) Cyclic AMP accumulation in cerebral cortical slices: effect of carbamazepine, phenobarbital, and phenytoin. Epilepsia 18, 237-242.
18. Ludvig N. and Moshe S. L. (1989) Different behavioral and electrographic effects of acoustic stimulation and dibutyryl cyclic AMP injection into the inferior colliculus in normal and in genetically epilepsy-prone rats. Epilepsy Res. 3, 185-190.
19. Ludvig N., Mishra P. K., and Jobe P. C. (1992) Dibutyryl cyclic AMP has epileptogenic potential in the hippocampus of freely behaving rats: a combined EEG-intracerebral microdialysis study. Neurosci. Lett. 141, 187-191.
20. Manji H. K., Chen G., Bitran J. A., Gusovsky F., and Potter W. Z. (1991) Chronic exposure of C6 glioma cells to desipramine desensitizes beta-adrenoceptors, but increases KL/KH ratio. Eur. J. Pharmacol. 206, 159-162.
21. Manji H. K., Rudorfer M. V., and Potter W. Z. (1994) Affective disorders and adrenergic function, in Adrenergic Dysfunction and Psychobiology (Cameron O. G., ed), pp. 157-180. American Psychiatric Press, Washington, D.C.
22. Manji H. K., Potter W. Z., and Lenox R. H. (1995a) Signal transduction pathways: molecular targets for lithium's actions. Arch. Gen. Psychiatry 52, 531-543.
23. Manji H. K., Chen G., Shimon H., Hsiao J. K., Potter W. Z., and Belmaker R. H. (1995b) Guanine nucleotide-binding proteins in bipolar affective disorder. Arch. Gen. Psychiatry 52, 135-144.
24. McLaughlin M. M., Cieshilinski L. B., Burman M., Torphy T. J., and Livi G. P. (1993) A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. J. Biol Chem. 268, 6470-6476.
25. Mork A. and Geisler A. (1992) Effects of lithium on second messenger systems in the brain. Pharmacol. Toxicol. 71 (Suppl. 1), 4-17.
26. Myllyla V. V. (1976) Effect of convulsions and anticonvulsive drugs on cerebrospinal fluid cyclic AMP in rabbit. Eur. Neurol. 14, 97-107.
27. 3H] forskolin to human platelet membranes. J Biol. Chem. 261, 13469-13473.
28. Palmer G. C. (1979) Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum. Exp. Neurol. 63, 322-335.
29. Palmer G. C., Jones D. J., Medina M. A., and Stavinoha W. B. (1979) Anticonvulsant drug actions on in vitro and in vivo levels of cyclic AMP in the mouse brain. Epilepsia 20, 95-104.
30. Pfeuffer E., Mollner S., and Pfeuffer T. (1991) Purification of adenylyl cyclase from heart and brain. Methods Enzymol. 195, 83-91.
31. Pfeuffer T. (1991) Synthesis of forskolin-agarose affinity matrices. Methods Enzymol. 195, 44-51.
32. Post R. M., Ballenger J. C., Uhde T. W., Smith C., Rubinow D. R., and Bunney W. E. Jr. (1982) Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol. Psychiatry 17, 1037-1045.
33. Post R. M., Ballenger J. C., Uhde T. W., and Bunney W. E. Jr. (1984) Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms, in Neurobiology of Mood Disorders (Post R. M. and Ballenger J. C., eds), pp. 777-816. Williams & Wilkins, Baltimore.
34. Post R. M., Weiss S. R., and Chuang D. M. (1992) Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J. Clin. Psychopharmacol. 12 (Suppl.), 23S-35S.
35. Purpura D. P. and Shofer R. J. (1972) Excitatory action of dibutyryl cyclic adenosine monophosphate on immature cerebral cortex. Brain Res. 38, 179-181.
36. Rabe C. S., Schneider J., and McGee R. Jr. (1982) Enhancement of depolarization-dependent neurosecretion from PC-12 cells by forskolin-induced elevation of cyclic AMP. J. Cyclic Nucleotide Res. 8, 371-384.
37. Rogawski M. A. and Porter R. J. (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising development stage compounds. Pharmacol. Rev. 42, 223-286.
38. Santiago M. and Westerink B. H. C. (1990) Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat. J. Neurochem. 55, 169-174.
39. Schoffelmeer A. N., Wardeh G., and Mulder A. H. (1985) Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine and 5-hydroxytryptamine from rat brain slices. Naunyn Schmiedebergs Arch. Pharmacol. 330, 74-76.
40. Sheng M. and Greenberg M. E. (1991) The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4, 477-485.
41. Spoto G., Whitehead E., Ferraro A., Di Terlizzi P. M., Turano C., and Riva F. (1991) A reverse-phase HPLC method for cAMP phosphodiesterase activity. Anal. Biochem. 196, 207-210.
42. Stiles G. (1992) Adenosine receptors. J. Biol. Chem. 267, 6451-6454.
43. Thompson W. J. (1991) Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol. Ther. 51, 13-33.
44. Ui M. (1990) Pertussis toxin as a valuable probe for G protein involvement in signal transduction, in ADP-Ribosylation Toxins and G Protein (Moss J. and Vaughn M., eds), pp. 45-79. American Society for Microbiology, Washington, D.C.
45. Van Calker D., Steber R., Klotz K. N., and Greil W. (1991) Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur. J. Pharmacol. 206, 285-290.
46. Wang L. Y., Salter M. W., and MacDonald J. F. (1991) Regulation of kainate receptor by cAMP-dependent protein kinase and phosphatases. Science 253, 1132-1135.
47. Weissman M. M., Leaf P. J., Tischler G. L., Blazer D. G., Karno M., Bruce M. L., and Florio L. P. (1988) Affective disorders in five United States communities. Psychosom. Med. 18, 141-153.
48. 3H] noradrenaline release from rat brain slices and on its presynaptic α-adrenergic modulation. J. Neurochem. 39, 349-356.
49. Williams S. F., Colling S. B., Whittington M. A., and Jefferys J. G. R. (1993) Epileptic focus induced by intrahippocampal cholera toxin in rat: time course and properties in vivo and in vitro. Epilepsy Res. 16, 137-146.
50. Yokoyama N., Mon N., and Kumashiro H. (1989) Chemical kindling induced by cAMP and transfer to electrical kindling. Brain Res. 492, 158-162.
51. sα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar disorder. J. Neurochem. 61, 890-898.
52. Young T., Li P. P., Kramble A., Siu K. P., and Warsh J. J. (1994) Mononuclear leukocyte levels of G-protein in depressed patients with bipolar disorder or major depressive disorder. Am. J. Psychiatry 151, 594-596.